Guo Shan-Shan, Zhao Yan, Hu Yan, Wang Xin-Ying, Zhao Xu-Zi, Zhong Pei-Yan, Luan Qin-Rong, Wang Zhe-Cheng, Yao Ji-Hong
Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian 116044, Liaoning Province, China.
Department of Pharmacology, Dalian Medical University, Dalian 116044, Liaoning Province, China.
World J Gastroenterol. 2025 Jun 14;31(22):105157. doi: 10.3748/wjg.v31.i22.105157.
Hepatic ischemia-reperfusion (I/R) injury related to liver transplantation and hepatic resection remains a challenge in clinical practice. Accumulating evidence indicates that mitochondrial dysfunction is a critical cause of I/R injury. The protein 4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1 (NIPSNAP1) is involved in the regulation of mitophagy and the recruitment of autophagy receptor proteins independent of PTEN induced putative kinase 1.
To clarify the protective mechanism of NIPSNAP1 against hepatic I/R, with a focus on mitophagy and mitochondrial dynamics, as well as the potential mechanism by which n6-methyladenosine (m6A) modification regulates NIPSNAP1.
Mice were administered an adeno-associated virus and a hepatic I/R model was established portal vein interruption followed by reperfusion to explore the effect of NIPSNAP1 on hepatic I/R. HepG2 cells were subjected to hypoxia/reoxygenation treatment .
We observed a significant downregulation of both NIPSNAP1 and insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) expression and . NIPSNAP1 knockdown impaired mitophagy and disrupted mitochondrial dynamics; in contrast, NIPSNAP1 overexpression resulted in the opposite effects. Further studies revealed that IGF2BP2 functions as an m6A reader that targets and binds NIPSNAP1, thereby regulating its mRNA stability.
NIPSNAP1 prevents hepatic I/R injury by promoting mitophagy and maintaining mitochondrial homeostasis, serving as a novel target of the m6A reader IGF2BP2. Therefore, targeting the IGF2BP2/NIPSNAP1 axis may facilitate the development of better therapeutics for hepatic I/R.
与肝移植和肝切除相关的肝缺血再灌注(I/R)损伤仍是临床实践中的一项挑战。越来越多的证据表明,线粒体功能障碍是I/R损伤的关键原因。蛋白4-硝基苯磷酸酶结构域和非神经元SNAP25样蛋白同源物1(NIPSNAP1)参与线粒体自噬的调节以及自噬受体蛋白的募集,且不依赖于PTEN诱导的假定激酶1。
阐明NIPSNAP1对肝I/R的保护机制,重点关注线粒体自噬和线粒体动力学,以及N6-甲基腺苷(m6A)修饰调节NIPSNAP1的潜在机制。
给小鼠注射腺相关病毒,并建立肝I/R模型(门静脉阻断后再灌注),以探究NIPSNAP1对肝I/R的影响。对HepG2细胞进行缺氧/复氧处理。
我们观察到NIPSNAP1和胰岛素样生长因子2 mRNA结合蛋白2(IGF2BP2)的表达均显著下调。敲低NIPSNAP1会损害线粒体自噬并破坏线粒体动力学;相反,过表达NIPSNAP1则产生相反的效果。进一步研究表明,IGF2BP2作为一种m6A阅读蛋白,靶向并结合NIPSNAP1,从而调节其mRNA稳定性。
NIPSNAP1通过促进线粒体自噬和维持线粒体稳态来预防肝I/R损伤,是m6A阅读蛋白IGF2BP2的新靶点。因此,靶向IGF2BP2/NIPSNAP1轴可能有助于开发更好的肝I/R治疗方法。